Home/Filings/4/0000874015-05-000024
4//SEC Filing

ISIS PHARMACEUTICALS INC 4

Accession 0000874015-05-000024

$IONSCIK 0000874015operating

Filed

Jul 5, 8:00 PM ET

Accepted

Jul 6, 5:57 PM ET

Size

5.1 KB

Accession

0000874015-05-000024

Insider Transaction Report

Form 4
Period: 2005-07-01
Wedel Mark K
VP & Chief Medical Officer
Transactions
  • Other

    Common Stock

    2005-07-01$3.36/sh+856$2,8748,060 total
Footnotes (1)
  • [F1]Reporting 856 shares acquired under the Isis Pharmaceuticals, Inc. 2000 Employee Stock Purchase Plan on July 1, 2005.

Issuer

ISIS PHARMACEUTICALS INC

CIK 0000874015

Entity typeoperating
IncorporatedCA

Related Parties

1
  • filerCIK 0000874015

Filing Metadata

Form type
4
Filed
Jul 5, 8:00 PM ET
Accepted
Jul 6, 5:57 PM ET
Size
5.1 KB